Marshall Wace, LLP Novo Nordisk A S Transaction History

Marshall Wace, LLP

  • $74.4 Billion
  • Q1 2025

A detailed history of Marshall Wace, LLP transactions in Novo Nordisk A S stock. As of the latest transaction made, Marshall Wace, LLP holds 25,125 shares of NVO stock, worth $1.77 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
25,125
Previous 1,167,498 97.85%
Holding current value
$1.77 Million
Previous $100 Million 98.26%
% of portfolio
0.0%
Previous 0.13%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025
SELL
$69.3 - $90.95 $79.2 Million - $104 Million
-1,142,373 Reduced 97.85%
25,125 $1.74 Million
Q4 2024

Feb 13, 2025
BUY
$85.0 - $120.04 $83.8 Million - $118 Million
986,195 Added 543.95%
1,167,498 $100 Million
Q3 2024

Nov 14, 2024
SELL
$119.07 - $145.42 $60.7 Million - $74.2 Million
-510,138 Reduced 73.78%
181,303 $21.6 Million
Q2 2024

Aug 14, 2024
BUY
$122.71 - $146.91 $84.6 Million - $101 Million
689,441 Added 34472.05%
691,441 $98.7 Million
Q1 2024

May 15, 2024
SELL
$102.11 - $135.92 $23.7 Million - $31.5 Million
-231,879 Reduced 99.14%
2,000 $256,000
Q4 2023

Feb 14, 2024
BUY
$87.78 - $105.45 $20.5 Million - $24.7 Million
233,879 New
233,879 $24.2 Million
Q2 2023

Aug 14, 2023
BUY
$155.98 - $172.65 $12.8 Million - $14.2 Million
82,160 Added 258.72%
113,916 $18.4 Million
Q1 2023

May 15, 2023
BUY
$132.34 - $159.14 $4.2 Million - $5.05 Million
31,756 New
31,756 $5.05 Million
Q3 2022

Nov 14, 2022
BUY
$95.28 - $116.93 $1.1 Million - $1.36 Million
11,592 New
11,592 $1.16 Million
Q2 2022

Aug 15, 2022
SELL
$103.24 - $121.81 $378,477 - $446,555
-3,666 Closed
0 $0
Q1 2022

May 16, 2022
SELL
$93.1 - $112.54 $81,276 - $98,247
-873 Reduced 19.23%
3,666 $407,000
Q4 2021

Feb 14, 2022
SELL
$95.88 - $117.08 $832,526 - $1.02 Million
-8,683 Reduced 65.67%
4,539 $508,000
Q3 2021

Nov 15, 2021
BUY
$84.42 - $106.62 $1.12 Million - $1.41 Million
13,222 New
13,222 $1.27 Million
Q1 2021

May 17, 2021
SELL
$67.06 - $75.82 $1.11 Million - $1.26 Million
-16,623 Closed
0 $0
Q4 2020

Feb 16, 2021
SELL
$63.89 - $73.8 $1.96 Million - $2.26 Million
-30,618 Reduced 64.81%
16,623 $1.16 Million
Q3 2020

Nov 16, 2020
BUY
$63.69 - $70.22 $3.01 Million - $3.32 Million
47,241 New
47,241 $3.28 Million
Q2 2020

Aug 13, 2020
SELL
$58.54 - $67.94 $47,593 - $55,235
-813 Closed
0 $0
Q1 2020

May 15, 2020
BUY
$49.46 - $64.78 $40,210 - $52,666
813 New
813 $49,000

Others Institutions Holding NVO

# of Institutions
1,768
Shares Held
330M
Call Options Held
11.3M
Put Options Held
15.5M
View Full List

About NOVO NORDISK A S

NVO Quotes by TradingView
  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $159B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Marshall Wace, LLP Portfolio

Follow Marshall Wace, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email